2180: hnRNP K overexpression drives acute myeloid leukemia emergence and progression

OBJECTIVES/SPECIFIC AIMS: Acute myeloid leukemia (AML) is a devastating hematologic malignancy wherein <20% of patients will survive 5 years after diagnosis. In an effort to understand alterations that drive AML development and progression, The Cancer Genome Atlas detailed the most common recurre...

Descripción completa

Detalles Bibliográficos
Autores principales: Hornbaker, Marisa, Gallardo, Miguel, Zhang, Xiaorui, Ma, Huaxian, Hu, Peter, Kornblau, Stephen, Bueso-Ramos, Carlos, Post, Sean
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2018
Materias:
Mechanistic Basic to Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6799187/
http://dx.doi.org/10.1017/cts.2017.207

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6799187/
http://dx.doi.org/10.1017/cts.2017.207

Ejemplares similares